Latest Regulatory Approvals News

Brazilian Rare Earths Limited (BRE) is demerging its Amargosa Bauxite-Gallium Project into Alurion Resources, with eligible shareholders receiving in-specie shares and access to a $30-50 million IPO.

Emperor Energy has submitted a revised Environmental Plan for its Judith-2 appraisal well and is advancing drilling preparations, including securing contractors and negotiating the Valaris-107 rig contract for a late Q1 2027 start.

ReNerve Limited has appointed UG Medical to distribute its NervAlign nerve repair products in Malaysia, tapping into a fast-growing healthcare market backed by government investment.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Matrix Composites & Engineering has lodged its Scheme Booklet with ASIC, setting the stage for a July shareholder vote on its proposed acquisition by Advanced Innergy Holdings. The deal, backed by an Independent Expert and the Matrix board, awaits court approval and shareholder endorsement.

Ardea Resources' Kalgoorlie Nickel Project – Goongarrie Hub has been awarded Lead Agency Status by the Western Australian Government, marking a key regulatory milestone that underscores its strategic importance in the critical minerals sector.

EBR Systems has secured a significant regulatory milestone as the US Centers for Medicare & Medicaid Services (CMS) initiates a National Coverage Determination (NCD) for its WiSE wireless cardiac pacing system, aiming for approval by early 2027.

TMK Energy reports a steady increase in gas output and launches a 1MW Gas to Power pilot in Mongolia, aiming to boost well performance and secure a production license.

Island Pharmaceuticals has kicked off GMP manufacturing of its antiviral Galidesivir to support late-stage Marburg virus studies under the FDA Animal Rule, marking a key step towards regulatory submission and biodefence readiness.

Optiscan Imaging has reached the halfway recruitment milestone in its first in-human breast cancer study, advancing its regulatory and commercial ambitions with promising clinical data and expanded trial sites.

Chalice Mining has outlined a compelling 2.5km copper-molybdenum-silver soil anomaly near Goomalling, WA, featuring rock chips with over 15% total rare earth oxides and strategic magnet rare earths. An initial drilling program is imminent.

DPM Metals has revealed a major new gold-copper porphyry discovery at its Brevene South Porphyry target adjacent to the Chelopech mine, with drill results showing broad intervals of high-grade mineralization and plans for an intensive follow-up drilling campaign.